Tolterodine Tartrate ER 24HR Capsules
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Amendment 0004 issued February 08, 2023 to extend the solicitation closing date from February 09, 2023 3:00 PM EST to February 17, 2023 3:00 PM EST.
Amendment 0003 issued January 26, 2023 to extend the solicitation closing date from Janaury 26, 2023 3:00 PM EST to February 09, 2023 3:00 PM EST.
Amendment 0002 issued January 05, 2023 to extend the solicitation closing date from Janaury 12, 2023 3:00 PM EST to January 26, 2023 3:00 PM EST.
Amendment 0001 issued December 16, 2022 to incorporate statement, DoD Class Deviation 2023-O0001, Verification of Eligibility of Small Business Joint Ventures, into solicitation.
Solicitation SPE2D2-23-R-0001 Tolterodine Tartrate ER 24HR 4MG and Tolterodine Tartrate ER 24HR 2MG Capsules